Blair William & Co. IL Purchases 2,486 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Blair William & Co. IL boosted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 3.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 75,450 shares of the biotechnology company’s stock after purchasing an additional 2,486 shares during the quarter. Blair William & Co. IL owned about 0.10% of Axon Enterprise worth $23,607,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Axon Enterprise by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 7,930,905 shares of the biotechnology company’s stock worth $2,048,791,000 after acquiring an additional 40,435 shares in the last quarter. Sands Capital Management LLC raised its stake in shares of Axon Enterprise by 0.6% in the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock worth $679,060,000 after purchasing an additional 16,347 shares during the last quarter. Norges Bank bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $195,406,000. Westfield Capital Management Co. LP boosted its position in shares of Axon Enterprise by 5.1% during the fourth quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after buying an additional 35,528 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in Axon Enterprise by 2.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock worth $150,027,000 after buying an additional 15,840 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 43,668 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the transaction, the insider now directly owns 189,719 shares in the company, valued at $58,801,506.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Jeffrey C. Kunins sold 43,668 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total value of $13,534,459.92. Following the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 308 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the transaction, the director now owns 1,607 shares of the company’s stock, valued at $498,282.49. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock worth $27,684,677 over the last ninety days. Company insiders own 6.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. JPMorgan Chase & Co. increased their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Bank of America assumed coverage on Axon Enterprise in a research note on Wednesday. They issued a “buy” rating and a $380.00 target price on the stock. Barclays lifted their price target on Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 8th. Finally, Jefferies Financial Group assumed coverage on Axon Enterprise in a research report on Wednesday. They set a “buy” rating and a $385.00 target price for the company. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $342.54.

Axon Enterprise Stock Performance

AXON traded up $2.78 on Friday, hitting $308.45. The company’s stock had a trading volume of 268,835 shares, compared to its average volume of 488,986. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87. The firm has a market cap of $23.28 billion, a P/E ratio of 89.45 and a beta of 0.95. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The company’s 50 day simple moving average is $292.37 and its 200-day simple moving average is $289.08.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.51 earnings per share. Analysts forecast that Axon Enterprise, Inc. will post 2.35 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.